← All companies

ELUT

Elutia Inc.

ELUT Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.87

-0.04 -4.21%

Key statistics

from XBRL data in SEC filings

Market cap

$37.3M

Revenue (TTM)

$12.5M

Net income (TTM)

$49.8M

EPS (TTM)

$0.91

P/E ratio

1.0

Dividend yield

—

Free cash flow

-$46.7M

Cash

$28.5M

Total assets

$55.2M

Gross margin

56.3%

52-week range

$0.50 – $2.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Regulation FD disclosure Jul 20, 2026 8-K Director or officer change; Shareholder vote results Jun 16, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Results of operations (earnings release) Mar 11, 2026 8-K Director or officer change Mar 9, 2026 8-K Other events Mar 4, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Delisting notice or listing-rule failure Jan 2, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Delisting notice or listing-rule failure Nov 12, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Director or officer change; Regulation FD disclosure Oct 14, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure; Other events Oct 7, 2025 8-K Entered a material agreement; Regulation FD disclosure Sep 9, 2025 8-K Entered a material agreement; Took on a direct financial obligation Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Shareholder vote results Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity May 8, 2025 8-K Terminated a material agreement; Regulation FD disclosure May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Entered a material agreement; Regulation FD disclosure Feb 4, 2025 8-K Results of operations (earnings release); Other events Feb 3, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Entered a material agreement; Took on a direct financial obligation Oct 3, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Entered a material agreement; Regulation FD disclosure Jun 18, 2024 8-K Regulation FD disclosure; Other events Jun 17, 2024 8-K Shareholder vote results Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Entered a material agreement Apr 1, 2024 10-K Fiscal year ended 2023-12-31 Mar 11, 2024 8-K Results of operations (earnings release) Mar 7, 2024